Corton Capital Inc. Annexon, Inc. Transaction History
Corton Capital Inc.
- $168 Million
- Q4 2024
A detailed history of Corton Capital Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 13,741 shares of ANNX stock, worth $35,864. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,741
Previous 17,441
21.21%
Holding current value
$35,864
Previous $103,000
32.04%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$19.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$18.3 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$17.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$16.4 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$14.7 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $124M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...